(Q38283317)
Statements
1 reference
The development of immunomodulatory monoclonal antibodies as a new therapeutic modality for cancer: the Bristol-Myers Squibb experience (English)
1 reference
David Berman
1 reference
Alan Korman
1 reference
Ronald Peck
1 reference
David Feltquate
1 reference
Nils Lonberg
1 reference
Renzo Canetta
1 reference
1 December 2014
1 reference
1 reference
148
1 reference
132-153
1 reference
Identifiers
1 reference
1 reference